Humanigen Sells Assets to Taran Therapeutics After FDA Denial, Backed by $2M Insider Loan
Humanigen filed chapter 11 in Delaware in January 2024 and sold assets to Taran via an insider $2M DIP-backed 363 process. Liquidating trust followed.
193 articles